A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials”.

Saved in:

Bibliographic Details
Title:	A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials”.
Authors:	Friedman, Scott M.¹ (AUTHOR) smfriedman83@hotmail.com, Xu, Yingxin² (AUTHOR), Sherman, Steven² (AUTHOR), Kuznik, Andreas² (AUTHOR), Mojebi, Ali³ (AUTHOR), Keeping, Sam³ (AUTHOR), Chan, Keith³ (AUTHOR), Leng, Theodore⁴ (AUTHOR), Patel, Nimesh^5,6 (AUTHOR)
Source:	Ophthalmology & Therapy. Jul2026, p1-4. 4p.
Database:	Academic Search Ultimate

Description
ISSN:	21938245
DOI:	10.1007/s40123-026-01439-5